Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intentional warfarin overdose.

Geoffrey K Isbister1, L Peter Hackett, Ian M Whyte

  • 1Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, New South Wales, Australia. gsbite@bigpond.com

Therapeutic Drug Monitoring
|November 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive overview of paracetamol poisoning admissions and long-term outcomes in New South Wales, Australia: a retrospective linked data cohort (PAVLOVA-3).

The Lancet regional health. Western Pacific·2026
Same author

A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11).

British journal of clinical pharmacology·2026
Same author

Poisoning in the elderly is increasing rapidly and is more severe than younger patients.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Understanding Consumer Attitudes and Awareness After Admission to a Toxicology Unit.

Emergency medicine Australasia : EMA·2026
Same author

An accurate and reproducible method to measure snake venom anticoagulant activity.

Journal of pharmacological and toxicological methods·2026
Same author

Neuromuscular and cytotoxic effects of common cobra (<i>Naja naja</i>) bites in rural Sri Lanka.

Clinical toxicology (Philadelphia, Pa.)·2025
Same journal

Deltamethrin Placental Transfer and Seasonal Pyrethroid Exposure: A Mother-Newborn Dyad Pilot Study.

Therapeutic drug monitoring·2026
Same journal

A Clustering-Based Grey Modeling Approach for Tacrolimus Concentration Prediction Under Sparse Therapeutic Drug Monitoring.

Therapeutic drug monitoring·2026
Same journal

Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements".

Therapeutic drug monitoring·2026
Same journal

Lacosamide Concentration in Various Biological Matrices (Plasma, Saliva, and Hair) Does Not Correlate with Clinical Outcomes in Patients with Epilepsy.

Therapeutic drug monitoring·2026
Same journal

Comparison of Creatinine-Based, Cystatin C-Based, and Combined Kidney Function Estimates for Vancomycin Clearance Prediction.

Therapeutic drug monitoring·2026
Same journal

Preemptive Pharmacogenetics in Renal Transplantation: A Real-World Assessment of Pharmacogenetic Actionability.

Therapeutic drug monitoring·2026
See all related articles

Warfarin overdose management requires careful vitamin K dosing to avoid thrombosis risks. Tailored treatment based on therapeutic warfarin use and INR levels ensures safe anticoagulation reversal.

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Toxicology

Background:

  • Warfarin toxicity, often from dose changes or interactions, presents management challenges, especially in patients on therapeutic anticoagulation.
  • Intentional warfarin overdose is rare but poses significant bleeding risks, complicated by the need to balance anticoagulation reversal with thrombosis prevention.
  • Existing management strategies for warfarin overdose require refinement to address complications and ensure patient safety.

Observation:

  • Three patients with warfarin overdose were studied, with two receiving a single 10-mg vitamin K dose, leading to anticoagulation needs and prolonged warfarin resistance in one case.
  • A third patient managed with incremental vitamin K doses (up to 7.5 mg) based on serial INR, factor levels, and warfarin concentrations avoided anticoagulation and resumed warfarin therapy within 4 days.
  • Patients were classified into nontherapeutic, moderate risk, and major risk groups based on pre-existing indications for warfarin, influencing management decisions.

Related Experiment Videos

Findings:

  • Patients not on therapeutic warfarin can receive 10 mg vitamin K1 as outpatients with repeat INR monitoring.
  • For INR > 5, titrating intravenous vitamin K (0.5–2.0 mg) is effective for INR reduction without inducing warfarin resistance.
  • High-risk patients require anticoagulation maintenance, necessitating avoidance of warfarin resistance.

Implications:

  • This study proposes a tiered management approach for intentional warfarin overdose based on patient risk stratification.
  • Safe and effective anticoagulation reversal can be achieved by carefully titrating vitamin K doses.
  • The findings offer guidance for clinicians managing warfarin overdose, minimizing complications and optimizing patient outcomes.